Biotech

Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Licence with Omics Global Extended to Chile

🕔12/20/2023 9:12:03 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce the signing of a licence agreement to expand PromarkerD's reach in Central and South America.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) AGM Chairman's Address and Investor Presentation

🕔11/23/2023 12:22:57 PM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the Chairman's Address provided by Mr Neville Gardiner and the Investor Presentation provided by Dr Richard Lipscombe to shareholders.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) US Medicare Confirms Reimbursement Price for PromarkerD

🕔11/22/2023 9:13:14 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that the US Centers for Medicare & Medicaid Services has published its final determination of the national reimbursement price in the United States for the PromarkerD predictive test for diabetic kidney disease.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Presents at Bell Potter Healthcare Conference

🕔11/13/2023 9:13:49 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to provide an opportunity for shareholders and investors to view a virtual presentation by Managing Director Dr Richard Lipscombe.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Receives $1.85 Million in R&D Tax Incentive

🕔11/9/2023 9:19:36 AM

Proteomics International Laboratories Ltd (ASX:PIQ) announces that its cash reserves have been further strengthened by the receipt of $1.85 million in research and development tax incentive for the 2022-23 financial year.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Investor Presentation

🕔10/30/2023 9:30:05 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of its latest investor presentation for a non-deal roadshow to institutional investors.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) September 2023 Quarterly Activities Report

🕔10/26/2023 9:10:42 AM

Proteomics International Laboratories Ltd (ASX:PIQ), a medical technology company at the forefront of precision medicine and predictive diagnostics, is pleased to provide the following update on its business activities for the three months to 30 September 2023 and subsequent to the period end.

Read Full Article